|
- 2017
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulationDOI: 10.1186/s12933-017-0510-1 Keywords: Arterial remodelling, Pulse wave analysis, Insulin resistance, SGLT2 inhibitors, Blood pressure, Scanning laser Doppler flowmetry, vascular protection Abstract: The sodium–glucose cotransporter 2 inhibitor, dapagliflozin, has been shown to improve diabetic control and reduce blood pressure in patients with type 2 diabetes mellitus. Its effects on micro- and macrovascular structure and function have not yet been reported
|